рус
eng
Strategic consulting
Developing market access strategy Development of marketing strategy Portfolio assessment and development Registration dossier and market authorization
Ongoing analytical review of the Russian health care system
PharmСompass Russia PharmСompass Regions PharmCompass ЕАСU
Market research Pharmacoeconomic analysis Patient support programs
Clinical patient registries
Diabetes Mellitus Rheumatoid Arthritis (RA) Juvenile Arthritis Hemic Diseases Pituitary Tumours mRCC Diabetic Foot Syndrome Medullary Thyroid Cancer Diabetes Insipidus Other registries
Epidemiological studies Laboratory diagnostics programs Biostatistics Clinical trials Pharmacovigilance programs
BI solutions Quinta platform and Quinta solutions
Quinta Clinical Quinta Care Quinta Lab
Websites and educations web-portals Mobile apps Expert Systems
Analytical products
Aston 360 Report PharmСompass Russia Report PharmСompass Regions Report PharmCompass ЕEU
PharMon databases
PharMon Tenders PharMon Import
Expert Audit BI solutions
Press room » Aston Health news » Aston Group has become a member of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR).
Anastasia Zhigalkina

Aston Group has become a member of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR).

Publication date: 18 june 2015

Aston Group has become a member of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR).

ISPOR is a reputable organization in the field of pharmacoeconomic surveys. Since its foundation in 1995 and to the present time the main goals of the Society have been obtaining reliable pharmacoeconomic data throughout the world to make health systems in different countries more efficient. 

CJSC Aston Consulting, 1999-2021
General Policy on Processing of Personal Data